You are here

  • Home
  • Archive
  • Volume 71, Issue 6
  • Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities

Article info

Article menu
Download PDFPDF
PostScript
Letter
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities

Authors

  • Yao-Chun Hsu School of Medicine, I-Shou University, Kaohsiung, Taiwan Center for Liver Diseases, E-Da Hospital, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Cheng-Hao Tseng School of Medicine, I-Shou University, Kaohsiung, Taiwan Gastroenterology and Hepatology, E-Da Cancer Hospital, Kaohsiung, Taiwan PubMed articlesGoogle scholar articles
  • Tung-Hung Su Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Hepatitis Research Center, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Jia-Horng Kao Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan Hepatitis Research Center, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan PubMed articlesGoogle scholar articles
  • Mindie H Nguyen Gastroenterology and Hepatology, Stanford University Medical Center, Palo Alto, California, USA Epidemiology and Population Health, Stanford University Medical Center, Palo Alto, California, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Yao-Chun Hsu, Center for Liver Diseases, E-Da Hospital, Kaohsiung 824, Taiwan; holdenhsu{at}ntu.edu.tw
View Full Text

Citation

Hsu Y, Tseng C, Su T, et al
Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities
Gut 2022;71:1238-1240.

Publication history

  • Received September 30, 2021
  • Accepted October 3, 2021
  • First published October 20, 2021.
Online issue publication 
October 18, 2023

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.